Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by pericles1on Nov 29, 2010 11:34am
337 Views
Post# 17770552

RE: RE: RE: RE: RE: ONC and Margin Accounts

RE: RE: RE: RE: RE: ONC and Margin Accounts

medhatman, I'm sure glad that you think risk is rung out because of Brad's multiple references to US H&N confirmation results after all Brad never exaggerates. Since results on the H&N confirmation are over a year late and since I don't have as much faith in Brad as you do, I'm more than a little nervous.

Right now I'm only interested in three things.

1. GOOD RESULTS IN CONFIRMATION H&N

2. GOOD PRELIMINARY RESULTS IN NSCLC TRIAL

3. GOOD NUMBERS ON ENROLLMENT SO THIS DOES NOT TAKE TWO YEARS FOR PHASE III A.

At this point point everything else except partnership is way down on my list!
Bullboard Posts